Halting HF in Patients With Diabetes: Insights From EMPA-REG Halting HF in Patients With Diabetes: Insights From EMPA-REG
A substudy of EMPA-REG finds that SGLT2 inhibitors may slow the onset of heart failure. Dr Pi ñ a discusses the research with study investigator Dr Javed Butler at ESC 2017.theheart.org on Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
More News: Cardiology | Diabetes | Endocrinology | Health | Heart | Heart Failure | SGLT2 Inhibitors | Study